T/SDACM 006-2024 Stability of Coronary Heart Disease: A Clinical Practice Guideline for Treating with Disharmony of Qi and Blood

Scope

Main technical content: Stable coronary heart disease is one of the most common subtypes of coronary heart disease in clinical practice, including chronic stable exertional angina, ischemic cardiomyopathy, and the stable phase of the disease after acute coronary syndrome [1]. With the development of the economy and society, and the acceleration of the aging and urbanization processes, the prevalence of stable coronary heart disease in China is on the rise. If not treated promptly and effectively, patients are prone to acute myocardial infarction, malignant arrhythmia, and sudden cardiac death, which impose a huge disease burden on families and society and have become a major public health issue [2]. Therefore, strengthening the prevention and treatment of stable coronary heart disease is of great significance for alleviating the economic pressure on individuals and families, improving the health level of the Chinese people, and promoting the sustainable development of the economy and society. Traditional Chinese medicine (TCM) is gradually showing advantages in the prevention and treatment of stable coronary heart disease. Multiple clinical research results show that TCM diagnosis and treatment can effectively improve patients' symptoms, enhance their quality of life, and reduce hospitalization rates and mortality rates [3]. The TCM theory of "imbalance of qi and blood" provides new insights into the understanding and diagnosis and treatment of coronary heart disease and is worth further exploration. However, there is currently a lack of systematic summaries and guidance documents on the application of this theory in the clinical practice of stable coronary heart disease. Based on this, this guideline is developed to further standardize the treatment of stable coronary heart disease with TCM and non-drug therapies based on the theory of "imbalance of qi and blood", and to improve the clinical efficacy of TCM in the treatment of stable coronary heart disease. This gu

Development Information

Related Standards